Pharmaceutical holding Binnopharm Group, part of Sistema JSFC, and Glenmark Pharmaceuticals Limited agreed on localization of production of Favipiravir for treatment of coronavirus at the sites of Binnopharm Group - Alium plant in Obolensk village, Moscow region and Biocom in Stavropol. The documents for registration certificate were submitted to the Ministry of Health of the Russian Federation at the end of 2020. Glenmark Pharmaceuticals Limited will be the supplier of the substance for the production of Favipiravir at Binnopharm Group sites.